Literature DB >> 17948046

A dual-targeted lentiviral vector homing in on prostate bone metastases.

Yufang Hu1, David Stout, Lily Wu.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17948046      PMCID： PMC2838424          DOI： 10.1038/sj.mt.6300317

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors.

Authors:  A Follenzi; G Sabatino; A Lombardo; C Boccaccio; L Naldini
Journal:  Hum Gene Ther       Date:  2002-01-20       Impact factor: 5.695

2.  Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.

Authors:  P N Reynolds; S A Nicklin; L Kaliberova; B G Boatman; W E Grizzle; I V Balyasnikova; A H Baker; S M Danilov; D T Curiel
Journal:  Nat Biotechnol       Date:  2001-09       Impact factor: 54.908

3.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  Retargeting gene delivery using surface-engineered retroviral vector particles.

Authors:  D Lavillette; S J Russell; F L Cosset
Journal:  Curr Opin Biotechnol       Date:  2001-10       Impact factor: 9.740

Review 5.  No false start for novel pseudotyped vectors.

Authors:  David Avram Sanders
Journal:  Curr Opin Biotechnol       Date:  2002-10       Impact factor: 9.740

Review 6.  Progress and problems with the use of viral vectors for gene therapy.

Authors:  Clare E Thomas; Anja Ehrhardt; Mark A Kay
Journal:  Nat Rev Genet       Date:  2003-05       Impact factor: 53.242

7.  Prostate-specific targeting using PSA promoter-based lentiviral vectors.

Authors:  D Yu; D Chen; C Chiu; B Razmazma; Y H Chow; S Pang
Journal:  Cancer Gene Ther       Date:  2001-09       Impact factor: 5.987

8.  Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.

Authors:  L Wu; J Matherly; A Smallwood; J Y Adams; E Billick; A Belldegrun; M Carey
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

Review 9.  Osteoblasts in prostate cancer metastasis to bone.

Authors:  Christopher J Logothetis; Sue-Hwa Lin
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

10.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728
View more
  2 in total

1.  Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Jung-Taek Kwon; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Sung-Jin Park; Hu-Lin Jiang; Ji-Hye Kim; Seong-Ho Hong; Bitna Kang; Duyeoul Kim; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Myung-Haing Cho
Journal:  Cell Oncol (Dordr)       Date:  2012-10-16       Impact factor: 6.730

2.  Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.

Authors:  Yi Lu; Yu Zhang; Guimin Chang; Jun Zhang
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.